In a recent analysis of whole‐genome sequencing data from the Accelerating Medicines Partnership‐Parkinson's Disease cohort, Bryant and colleagues found that the 5′ variant rs76904798 was associated with LRRK2 p.R1514Q and p.N2081D.33 This evidence concerns the gene LRRK2 and Parkinson disease.